These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 483258)

  • 21. Differences in the reactivities of human urokinase and the porcine tissue plasminogen activator.
    Thorsen S; Astrup T
    Haemostasis; 1976; 5(5):295-305. PubMed ID: 14058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro measurement of fibrinolysis by urokinase].
    Senf L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):819-21. PubMed ID: 6176506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombolytic agents: effects of local infusion on microvascular physiology and macrovascular ultrastructure.
    Becker GJ; Rabe FE; Hogan RD; Evan AP; Franklin TD; Holden RW; Bang NU; Dilley RS; Bendick PJ; Klatte EC
    Radiology; 1983 Aug; 148(2):403-6. PubMed ID: 6346388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inhibitory effect of plasma inhibitor on plasmin activated with streptokinase or urokinase.
    Sumi H; Takada Y; Takada A
    Nihon Seirigaku Zasshi; 1977; 39(5):112-4. PubMed ID: 72149
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacology of fibrinolytics].
    Klöcking HP
    Z Gesamte Inn Med; 1979 Jan; 34(1):22-8. PubMed ID: 373275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary thrombolysis: pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA).
    Fox KA; Bergmann SR; Sobel BE
    Biochem Pharmacol; 1984 Jun; 33(12):1831-8. PubMed ID: 6233982
    [No Abstract]   [Full Text] [Related]  

  • 28. Vasodilation due to urokinase in the canine femoral circulation.
    Gurll NJ; Zinner MJ; Callahan W; Reynolds DG
    J Pharmacol Exp Ther; 1977 Jun; 201(3):731-7. PubMed ID: 864605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activating effect of the plasminogen activators on plasminogens of different mammalia species.
    Yakovlev SA; Rublenko MV; Izdepsky VI; Makogonenko EM
    Thromb Res; 1995 Aug; 79(4):423-8. PubMed ID: 7482446
    [No Abstract]   [Full Text] [Related]  

  • 30. Exchange of plasminogen activator between solution and intima.
    Gall W; Gurll NJ; Wright CB; Reynolds DG
    J Surg Res; 1979 May; 26(5):523-7. PubMed ID: 439883
    [No Abstract]   [Full Text] [Related]  

  • 31. Kinetic studies of three different molecular forms of urokinase for the activation of native human plasminogen.
    Toki N; Takasugi S; Sumi H
    Enzyme; 1981; 26(4):221-4. PubMed ID: 6788545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the fibrinolytic system.
    Robison AK; Collen D
    Cardiol Clin; 1987 Feb; 5(1):13-9. PubMed ID: 3103919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular mechanisms of thrombolytic therapy].
    Lijnen HR; Collen D
    Haemostasis; 1986; 16 Suppl 4():3-15. PubMed ID: 2945768
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential effects of activation of prothrombin by streptokinase compared with urokinase and tissue-type plasminogen activator (t-PA).
    Eisenberg PR; Miletich JP; Sobel BE; Jaffe AS
    Thromb Res; 1988 Jun; 50(5):707-17. PubMed ID: 3137687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the abilities of plasma kallikrein, beta-Factor XIIa, Factor XIa and urokinase to activate plasminogen.
    Miles LA; Greengard JS; Griffin JH
    Thromb Res; 1983 Feb; 29(4):407-17. PubMed ID: 6344314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A; Takada Y
    Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on activator formation in human plasma with streptokinase. III. Investigation of activator kinetics in undiluted plasma in terms of urokinase equivalents.
    Martin M
    Thromb Haemost; 1976 Dec; 36(3):566-81. PubMed ID: 138962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-chain urokinase-type plasminogen activator: mechanism of action and thrombolytic properties.
    Lijnen HR; Stump DC; Collen DC
    Semin Thromb Hemost; 1987 Apr; 13(2):152-9. PubMed ID: 3114883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.